Tech Company Financing Transactions
Insamo Funding Round
Insamo closed a $12 million Seed funding round on 2/21/2024. Backers included Axial VC, Civilization Ventures and MRL Ventures.
Transaction Overview
Company Name
Announced On
2/21/2024
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to expand operations and development efforts.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
2630 Bancroft Way
Berkeley, CA 94704
USA
Berkeley, CA 94704
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Insamo's mission is to transform how we discover drugs for some of the most challenging diseases. Our platform's pioneering capability lies in its automated process of designing, synthesizing, and testing at an unprecedented scale. Our groundbreaking approach enables us to iterate our design cycle using trillions of proprietary experimental data points across an astronomical drug-like chemical space which we believe sets an entirely new standard for the application of scalable machine learning to drug design.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tim Craven
Chief Operating Officer
Glen McIntyre
Chief Scientific Officer
Toby Passioura
Browse more venture capital transactions:
Prev: 2/21/2024: HealthSnap venture capital transaction
Next: 2/21/2024: Cagent Vascular venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs